Cargando…

Investigation of potential substandard dry powder inhalers on EU and North African markets – evaluation of the delivered and fine particle doses

PURPOSE: Discovery of falsified Symbicort 320/9 Turbohaler identified in the UK in 2013 demonstrated that falsified dry powder inhalers were also present in the European market. This work aimed to investigate the current situation of formoterol-containing dry powder inhalers in Europe and North Afri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yue, Hubert, Philippe, Hubert, Cédric
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Respiratory Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543106/ https://www.ncbi.nlm.nih.gov/pubmed/36213210 http://dx.doi.org/10.1080/21556660.2022.2125727

Ejemplares similares

A randomised controlled trial of small particle inhaled steroids in refractory eosinophilic asthma (SPIRA)
por: Hodgson, David, et al.
Publicado: (2015)

Impact of changes to reimbursement of fixed combinations of inhaled corticosteroids and long-acting β(2)-agonists in obstructive lung diseases: a population-based, observational study
por: Björnsdóttir, U S, et al.
Publicado: (2014)

Numerical Modeling of Particle Dynamics Inside a Dry Powder Inhaler
por: Šušteršič, Tijana, et al.
Publicado: (2022)

A retrospective database study comparing treatment outcomes and cost associated with choice of fixed-dose inhaled corticosteroid/long-acting β(2)-agonists for asthma maintenance treatment in Germany
por: Aballéa, S, et al.
Publicado: (2008)

Substandard Quality of the Antimicrobials Sold in the Street Markets in Haiti
por: Jean-Baptiste, Théodule, et al.
Publicado: (2020)

Optimizing Spray-Dried Porous Particles for High Dose Delivery with a Portable Dry Powder Inhaler
por: Son, Yoen-Ju, et al.
Publicado: (2021)

Rat model of smoke inhalation-induced acute lung injury
por: Leiphrakpam, Premila Devi, et al.
Publicado: (2021)

Simultaneous Spray Drying for Combination Dry Powder Inhaler Formulations
por: Shepard, Kimberly B., et al.
Publicado: (2022)

Ciprofloxacin dry powder inhaler in cystic fibrosis
por: Elborn, J Stuart
Publicado: (2016)

Understanding the Importance of Capsules in Dry Powder Inhalers
por: Buttini, Francesca, et al.
Publicado: (2021)

Flow and Particle Modelling of Dry Powder Inhalers: Methodologies, Recent Development and Emerging Applications
por: Zheng, Zhanying, et al.
Publicado: (2021)

Evaluation of inhaler handling-errors, inhaler perception and preference with Spiromax, Easyhaler and Turbuhaler devices among healthy Finnish volunteers: a single site, single visit crossover study (Finhaler)
por: Sandler, Niklas, et al.
Publicado: (2016)

The Effect of Particle Size and Surface Roughness of Spray-Dried Bosentan Microparticles on Aerodynamic Performance for Dry Powder Inhalation
por: Kwon, Yong-Bin, et al.
Publicado: (2020)

Effect of Inhaler Design Variables on Paediatric Use of Dry Powder Inhalers
por: Lexmond, Anne J., et al.
Publicado: (2014)

Inhaled therapies for chronic obstructive pulmonary disease: a systematic review and meta-analysis
por: Axson, Eleanor L, et al.
Publicado: (2020)

Chemical exposure and alveolar macrophages responses: ‘the role of pulmonary defense mechanism in inhalation injuries’
por: Tapak, Mahtab, et al.
Publicado: (2023)

Pharmacokinetics of Salmeterol and Fluticasone Propionate Delivered in Combination via Easyhaler and Diskus Dry Powder Inhalers in Healthy Subjects
por: Kirjavainen, Merja, et al.
Publicado: (2018)

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
por: Phillips, Jonathan E., et al.
Publicado: (2017)

Manipulation of Spray-Drying Conditions to Develop an Inhalable Ivermectin Dry Powder
por: Saha, Tushar, et al.
Publicado: (2022)

Preparation of slab-shaped lactose carrier particles for dry powder inhalers by air jet milling
por: Kou, Xiang, et al.
Publicado: (2017)

Usability and Robustness of the Wixela Inhub Dry Powder Inhaler
por: Allan, Richard, et al.
Publicado: (2021)

Radiolabeling Method for Lyophilizate for Dry Powder Inhalation Formulations
por: Miyamoto, Kahori, et al.
Publicado: (2022)

Feedback systems in multi-dose dry powder inhalers
por: Emeryk, Andrzej, et al.
Publicado: (2022)

Dry Powder Inhalation for Lung Delivery in Cystic Fibrosis
por: Han, Xiaoxuan, et al.
Publicado: (2023)

Do statins improve outcomes in patients with asthma on inhaled corticosteroid therapy? A retrospective cohort analysis
por: Lokhandwala, Tasneem, et al.
Publicado: (2012)

Validation of a metered dose inhaler electronic monitoring device: implications for asthma clinical trial use
por: Pilcher, Janine, et al.
Publicado: (2016)

Identification of responders to inhaled corticosteroids in a chronic obstructive pulmonary disease population using cluster analysis
por: Hinds, David R, et al.
Publicado: (2016)

Environmental impact of inhalers for respiratory diseases: decreasing the carbon footprint while preserving patient-tailored treatment
por: Panigone, Sara, et al.
Publicado: (2020)

Impact of smoking status on the efficacy of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review
por: Sonnex, Kimberley, et al.
Publicado: (2020)

Effect of compression pressure on inhalation grade lactose as carrier for dry powder inhalations
por: Raut, Neha Sureshrao, et al.
Publicado: (2016)

Appropriate use of a dry powder inhaler based on inhalation flow pattern
por: Kondo, Tetsuri, et al.
Publicado: (2017)

Stratified assessment of the role of inhaled hypertonic saline in reducing cystic fibrosis pulmonary exacerbations: a retrospective analysis
por: Dmello, Dayton, et al.
Publicado: (2011)

Health-care Resource Requirements and Potential Financial Consequences of an Environmentally Driven Switch in Respiratory Inhaler Use in England
por: Attar-Zadeh, Darsuh, et al.
Publicado: (2021)

THE EFFECTS OF THE ANTECEDENT USE OF INHALED STEROID ON THE CLINICAL COURSE OF COVID-19: A RETROSPECTIVE STUDY OF PATIENTS WITH ASTHMA
por: ALHARBI, E., et al.
Publicado: (2022)

PROMETHEUS: Long-Term Exacerbation and Mortality Benefits of Implementing Single-Inhaler Triple Therapy in the US COPD Population
por: Criner, Gerard, et al.
Publicado: (2023)

Delivery characteristics of a low-resistance dry-powder inhaler used to deliver the long-acting muscarinic antagonist glycopyrronium*
por: Colthorpe, Paul, et al.
Publicado: (2013)

Which patients with chronic obstructive pulmonary disease benefit from the addition of an inhaled corticosteroid to their bronchodilator? A cluster analysis
por: DiSantostefano, Rachael L, et al.
Publicado: (2013)

Costs of switching to low global warming potential inhalers. An economic and carbon footprint analysis of NHS prescription data in England
por: Wilkinson, Alexander J K, et al.
Publicado: (2019)

An Overview on Spray-Drying of Protein-Loaded Polymeric Nanoparticles for Dry Powder Inhalation
por: Marante, Tânia, et al.
Publicado: (2020)

‘The blue one takes a battering’ why do young adults with asthma overuse bronchodilator inhalers? A qualitative study
por: Cole, Sue, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_68rjk4ecveqmqdvl2qo58bu8c7